Global Drugs Glass Packaging Market Research Report 2024
Published on: 2024-01-04 | No of Pages : 400 | Industry : Packaging
Publisher : MRA | Format : PDF
Global Drugs Glass Packaging Market Research Report 2024
Pharmaceutical Glass Packaging has a broad range of containers, including injectable, transfusion, diagnostic and syrup bottles, and offers a choice of glass type (I, II, III) and color (clear or amber).
According to MRAResearch’s new survey, global Drugs Glass Packaging market is projected to reach US$ 6634.8 million in 2029, increasing from US$ 5315 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drugs Glass Packaging market research.
The pharma glass bottle packaging market is driven by several key factors. Firstly, the increasing demand for pharmaceutical products, driven by a growing aging population and the prevalence of chronic diseases, has led to a rise in the need for reliable and safe packaging solutions. Glass bottles offer excellent protection against contamination and maintain the integrity of sensitive pharmaceutical formulations, ensuring product efficacy and shelf life. Secondly, stringent regulations and quality standards enforced by regulatory authorities necessitate the use of high-quality packaging materials, making glass a preferred choice due to its inert and non-reactive nature. However, the market faces challenges, such as the higher production costs of glass bottles compared to plastic alternatives. Additionally, the weight and fragility of glass bottles can increase transportation costs and pose logistical challenges for manufacturers and distributors. Striking a balance between product safety and cost-effectiveness remains a critical challenge for the pharma glass bottle packaging market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Drugs Glass Packaging market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Gerresheimer
Schott
Stevanato Group
Shandong PG
SGD
Nipro
Ardagh
Bormioli Pharma
West Pharmaceutical
Sisecam Group
Corning Incorporated
PGP Glass
Zhengchuan Pharmaceutical
Stoelzle Glass
Chengdu Jinggu
Segment by Type
Cartridges
Vials
Ampoules
Others
Injection
Transfusion
Others
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Drugs Glass Packaging report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source
According to MRAResearch’s new survey, global Drugs Glass Packaging market is projected to reach US$ 6634.8 million in 2029, increasing from US$ 5315 million in 2022, with the CAGR of 5.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Drugs Glass Packaging market research.
The pharma glass bottle packaging market is driven by several key factors. Firstly, the increasing demand for pharmaceutical products, driven by a growing aging population and the prevalence of chronic diseases, has led to a rise in the need for reliable and safe packaging solutions. Glass bottles offer excellent protection against contamination and maintain the integrity of sensitive pharmaceutical formulations, ensuring product efficacy and shelf life. Secondly, stringent regulations and quality standards enforced by regulatory authorities necessitate the use of high-quality packaging materials, making glass a preferred choice due to its inert and non-reactive nature. However, the market faces challenges, such as the higher production costs of glass bottles compared to plastic alternatives. Additionally, the weight and fragility of glass bottles can increase transportation costs and pose logistical challenges for manufacturers and distributors. Striking a balance between product safety and cost-effectiveness remains a critical challenge for the pharma glass bottle packaging market.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Drugs Glass Packaging market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Gerresheimer
Schott
Stevanato Group
Shandong PG
SGD
Nipro
Ardagh
Bormioli Pharma
West Pharmaceutical
Sisecam Group
Corning Incorporated
PGP Glass
Zhengchuan Pharmaceutical
Stoelzle Glass
Chengdu Jinggu
Segment by Type
Cartridges
Vials
Ampoules
Others
Segment by Application
Injection
Transfusion
Others
Consumption by Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
The Drugs Glass Packaging report covers below items
Chapter 1Product Basic Information (Definition, Type and Application)
Chapter 2Manufacturers’ Competition Patterns
Chapter 3Country Level Sales Analysis
Chapter 4Product Type Analysis
Chapter 5Product Application Analysis
Chapter 6Manufacturers’ Outline
Chapter 7Industry Chain, Market Channel and Customer Analysis
Chapter 8Market Opportunities and Challenges
Chapter 9Market Conclusions
Chapter 10Research Methodology and Data Source